154 related articles for article (PubMed ID: 13679858)
21. Amino terminal, but not the carboxy terminal, sequences of tropomyosin-1 are essential for the induction of stress fiber assembly in neoplastic cells.
Bharadwaj S; Shah V; Tariq F; Damartoski B; Prasad GL
Cancer Lett; 2005 Nov; 229(2):253-60. PubMed ID: 16122869
[TBL] [Abstract][Full Text] [Related]
22. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
23. An osteopontin splice variant induces anchorage independence in human breast cancer cells.
He B; Mirza M; Weber GF
Oncogene; 2006 Apr; 25(15):2192-202. PubMed ID: 16288209
[TBL] [Abstract][Full Text] [Related]
24. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
25. Expression of a novel cardiac-specific tropomyosin isoform in humans.
Denz CR; Narshi A; Zajdel RW; Dube DK
Biochem Biophys Res Commun; 2004 Aug; 320(4):1291-7. PubMed ID: 15249230
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas.
Zisman-Rozen S; Fink D; Ben-Izhak O; Fuchs Y; Brodski A; Kraus MH; Bejar J; Ron D
Oncogene; 2007 Sep; 26(41):6093-8. PubMed ID: 17420726
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
28. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
29. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis.
Mollenhauer J; Helmke B; Medina D; Bergmann G; Gassler N; Müller H; Lyer S; Diedrichs L; Renner M; Wittig R; Blaich S; Hamann U; Madsen J; Holmskov U; Bikker F; Ligtenberg A; Carlén A; Olsson J; Otto HF; O'Malley B; Poustka A
Genes Chromosomes Cancer; 2004 Mar; 39(3):185-94. PubMed ID: 14732920
[TBL] [Abstract][Full Text] [Related]
30. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
[TBL] [Abstract][Full Text] [Related]
31. N terminus is essential for tropomyosin functions: N-terminal modification disrupts stress fiber organization and abolishes anti-oncogenic effects of tropomyosin-1.
Bharadwaj S; Hitchcock-DeGregori S; Thorburn A; Prasad GL
J Biol Chem; 2004 Apr; 279(14):14039-48. PubMed ID: 14722123
[TBL] [Abstract][Full Text] [Related]
32. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
33. ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2.
Jandrig B; Seitz S; Hinzmann B; Arnold W; Micheel B; Koelble K; Siebert R; Schwartz A; Ruecker K; Schlag PM; Scherneck S; Rosenthal A
Oncogene; 2004 Dec; 23(57):9295-302. PubMed ID: 15489893
[TBL] [Abstract][Full Text] [Related]
34. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
35. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
36. Dieldrin promotes resistance to anoikis in breast cancer cells in vitro.
Cameron HL; Foster WG
Reprod Toxicol; 2008 Feb; 25(2):256-62. PubMed ID: 18242054
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.
Veeck J; Geisler C; Noetzel E; Alkaya S; Hartmann A; Knüchel R; Dahl E
Carcinogenesis; 2008 May; 29(5):991-8. PubMed ID: 18356147
[TBL] [Abstract][Full Text] [Related]
39. Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues.
Walzak AA; Veldhoen N; Feng X; Riabowol K; Helbing CC
Exp Cell Res; 2008 Jan; 314(2):273-85. PubMed ID: 17720155
[TBL] [Abstract][Full Text] [Related]
40. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
Jiang K; Delarue FL; Sebti SM
Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
